In press future contents
Articles accepted for publication and currently in press. In this page a list of future contents of CER.
Full Papers
CER18937
Free to view
Investigation of alexithymia levels in fibromyalgia before and after treatment
M. Atasoy, E. Kalaoglu, U. Takim, H. Gokcay
DOI: https://doi.org/10.55563/clinexprheumatol/45nmy7
M. Atasoy, E. Kalaoglu, U. Takim, H. Gokcay
DOI: https://doi.org/10.55563/clinexprheumatol/45nmy7
CER18777
Free to view
Does different administration method of methotrexate matter in early rheumatoid arthritis? An exploratory register-based study
L. Weman, H. Salo, V. Rantalaiho, J. Huhtakangas, L. Kuusalo, P. Vähäsalo, M. Backström, T. Sokka-Isler
DOI: https://doi.org/10.55563/clinexprheumatol/tg7hxr
L. Weman, H. Salo, V. Rantalaiho, J. Huhtakangas, L. Kuusalo, P. Vähäsalo, M. Backström, T. Sokka-Isler
DOI: https://doi.org/10.55563/clinexprheumatol/tg7hxr
CER18779
Serum NLRC3 levels in systemic lupus erythematosus: correlation with clinical characteristics
W. Li, X. Gu, S. Liu, C. Chen, X. He, B. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/h3m8hl
W. Li, X. Gu, S. Liu, C. Chen, X. He, B. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/h3m8hl
CER18788
Free to view
Modification of cardiovascular risk factors after viscosupplementation with hyaluronic acid in patients with symptomatic hip and knee osteoarthritis
A.M. García-Bravo, M.Á. Ruiz-Fernández, A. Taboada Vázquez, A. Vizcaíno-Arzola, O. Del Rey Echevarría, M. Rufino-Navarro, L. Pérez-Méndez, F.J. De león-García
DOI: https://doi.org/10.55563/clinexprheumatol/tsa1u8
A.M. García-Bravo, M.Á. Ruiz-Fernández, A. Taboada Vázquez, A. Vizcaíno-Arzola, O. Del Rey Echevarría, M. Rufino-Navarro, L. Pérez-Méndez, F.J. De león-García
DOI: https://doi.org/10.55563/clinexprheumatol/tsa1u8
CER18823
Predictions of rheumatoid arthritis burden in 204 countries and territories by 2044: based on the Global Burden of Disease Study 2021
W. Zhang, D. Zhuang, H. Lu, Z. Lv, L. Huang, H. Du, J. Chang, M. Xiao, M. Chen, W. Ying, H. Lei, X. Li
DOI: https://doi.org/10.55563/clinexprheumatol/7dijpb
W. Zhang, D. Zhuang, H. Lu, Z. Lv, L. Huang, H. Du, J. Chang, M. Xiao, M. Chen, W. Ying, H. Lei, X. Li
DOI: https://doi.org/10.55563/clinexprheumatol/7dijpb
CER18832
Circulating microRNAs associated with tumour necrosis factor or fibloblast-like synoviocyte predict cartilage damage in early rheumatoid arthritis treated with methotrexate plus adalimumab: a subanalysis of the MIRACLE study
Y. Hosokawa, Y. Yoshida, H. Tamai, S. Hirata, K. Ikeda, T. Miyamoto, H. Taguchi, C.-F. Kuo, K. Shin, K. Izumi, Y. Kondo, H. Yasuoka, M. Kuwana, T. Ishii, H. Kameda, T. Kojima, M. Mori, Y. Sato, W.-C. Tsai, T. Takeuchi, Y. Kaneko
Collaborator/s: Y. Okano, S. Sato, T. Gono, K. Yoshimoto, I.A. Choi, S.-H. Park, M.-Y. Weng, Y.J. Lee, J. Kim, H.J. Baek, P.-N. Hsu, C.-M. Huang, T.-T. Cheng, W.-Y. Sung
the MIRACLE study collaborators
DOI: https://doi.org/10.55563/clinexprheumatol/keymab
Y. Hosokawa, Y. Yoshida, H. Tamai, S. Hirata, K. Ikeda, T. Miyamoto, H. Taguchi, C.-F. Kuo, K. Shin, K. Izumi, Y. Kondo, H. Yasuoka, M. Kuwana, T. Ishii, H. Kameda, T. Kojima, M. Mori, Y. Sato, W.-C. Tsai, T. Takeuchi, Y. Kaneko
Collaborator/s: Y. Okano, S. Sato, T. Gono, K. Yoshimoto, I.A. Choi, S.-H. Park, M.-Y. Weng, Y.J. Lee, J. Kim, H.J. Baek, P.-N. Hsu, C.-M. Huang, T.-T. Cheng, W.-Y. Sung
the MIRACLE study collaborators
DOI: https://doi.org/10.55563/clinexprheumatol/keymab
CER18854
Effects of cetylated fatty acids on knee osteoarthritis: a systematic review and meta-analysis of real-world evidence
K.-M. Tung, P.-H. Pan, Y.-T. Lin, N.T. Nhu, J.-L. Wu, C.-C. Hu, C. Chen, W.-H. Hou
DOI: https://doi.org/10.55563/clinexprheumatol/gtfx9p
K.-M. Tung, P.-H. Pan, Y.-T. Lin, N.T. Nhu, J.-L. Wu, C.-C. Hu, C. Chen, W.-H. Hou
DOI: https://doi.org/10.55563/clinexprheumatol/gtfx9p
CER18861
Free to view
Estimating the reliability of salivary gland ultrasound scoring in Sjögren’s disease: the outcome of an international training workshop
M. Suludere, N.R. Sluijpers, S. Arends, A.J. Stel, S. Jousse-Joulin, A. Hočevar, H. Bootsma, A. Vissink, K. Delli
Collaborator/s: A. Thatayatikom, A. Baer, A. Dumusc, A.C.F. Motta, A.S. Franco, A. Marino, C. Baldini, E. Maeland, F.R. De Oliveira, G. La Rocca, G. Fulvio, H. Munk, J. Gales, J. He, J. Van Santen, K.-A. Lee, M. Jonsson, M.L. Lemos Lopes, M. Tomiita, P. Olsson, S. Pringle, S. Cha, S. Liefers, V. Risso, V.F.M. Trevisani, Y. Jin, Y. Inoue
International Training Workshop
DOI: https://doi.org/10.55563/clinexprheumatol/derjeb
M. Suludere, N.R. Sluijpers, S. Arends, A.J. Stel, S. Jousse-Joulin, A. Hočevar, H. Bootsma, A. Vissink, K. Delli
Collaborator/s: A. Thatayatikom, A. Baer, A. Dumusc, A.C.F. Motta, A.S. Franco, A. Marino, C. Baldini, E. Maeland, F.R. De Oliveira, G. La Rocca, G. Fulvio, H. Munk, J. Gales, J. He, J. Van Santen, K.-A. Lee, M. Jonsson, M.L. Lemos Lopes, M. Tomiita, P. Olsson, S. Pringle, S. Cha, S. Liefers, V. Risso, V.F.M. Trevisani, Y. Jin, Y. Inoue
International Training Workshop
DOI: https://doi.org/10.55563/clinexprheumatol/derjeb
CER18889
Recurrence of thrombosis in patients with primary antiphospholipid syndrome: emphasis on arterial events
A.R. Cabral, A. Turrent-Carriles, I. Contreras-Yáñez, A. Garcia-Torralba, G. Hernandez-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/t0xgtk
A.R. Cabral, A. Turrent-Carriles, I. Contreras-Yáñez, A. Garcia-Torralba, G. Hernandez-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/t0xgtk
CER18899
Free to view
Tracheobronchial stenosis in patients with granulomatosis with polyangiitis: histopathological findings and long-term outcome
L. Linde, M. Faurschou, S.B. Krintel, B. Baslund
DOI: https://doi.org/10.55563/clinexprheumatol/xqt7su
L. Linde, M. Faurschou, S.B. Krintel, B. Baslund
DOI: https://doi.org/10.55563/clinexprheumatol/xqt7su
CER19044
Long-term outcome and clinicopathological characteristics of propylthiouracil-induced ANCA-associated glomerulonephritis: a case-control study
D. Wu, R. Zhang, X. Wang, Y. Rong, Z. Liu, W. Hu, J. Wang, H. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/johu1h
D. Wu, R. Zhang, X. Wang, Y. Rong, Z. Liu, W. Hu, J. Wang, H. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/johu1h
CER18935
The application value of peripheral plasmablasts in the assessment of disease activity and treatment response in systemic lupus erythematosus.
L. Wan, J. Guo, A. Sun, H. Chen, B. Hu, C. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/xsjjih
L. Wan, J. Guo, A. Sun, H. Chen, B. Hu, C. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/xsjjih
CER18757
Quality of life in patients with Sjögren’s disease: a bibliometric analysis
W. Liu, Z. Guo, X. Wang, N. Lu, X. Tang, Q. Jiang, X. Zhou
DOI: https://doi.org/10.55563/clinexprheumatol/ujdncl
W. Liu, Z. Guo, X. Wang, N. Lu, X. Tang, Q. Jiang, X. Zhou
DOI: https://doi.org/10.55563/clinexprheumatol/ujdncl
CER18958
Cardiac strain in patients on Janus Kinase inhibitors for rheumatic diseases: a 1-year echocardiographic study
N. Kougkas, E. Skouvaklidou, K. Tsafis, D. Deligeorgakis, V. Skepastianos, C. Adamichou, E. Papadimitriou, A. Mpitouli, M. Boutel, F. Dimitriadis, G. Spagos, I. Zarifis, T. Dimitroulas, A. Tsaousidis
DOI: https://doi.org/10.55563/clinexprheumatol/al5kv6
N. Kougkas, E. Skouvaklidou, K. Tsafis, D. Deligeorgakis, V. Skepastianos, C. Adamichou, E. Papadimitriou, A. Mpitouli, M. Boutel, F. Dimitriadis, G. Spagos, I. Zarifis, T. Dimitroulas, A. Tsaousidis
DOI: https://doi.org/10.55563/clinexprheumatol/al5kv6
CER18966
Evaluating the metabolic score for insulin resistance in patients with systemic lupus erythematosus
A. Aznar-Esquivel, M. Hernández-González, M. García-González, F. Gómez-Bernal, J.C. Quevedo-Abeledo, C. Almeida-Santiago, A. Molina-Tercero, E. Heras-Recuero, A. De vera-González, A. González-Delgado, B. Tejera-Segura, M.Á. González-Gay, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/m42g9r
A. Aznar-Esquivel, M. Hernández-González, M. García-González, F. Gómez-Bernal, J.C. Quevedo-Abeledo, C. Almeida-Santiago, A. Molina-Tercero, E. Heras-Recuero, A. De vera-González, A. González-Delgado, B. Tejera-Segura, M.Á. González-Gay, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/m42g9r
CER18985
Clinical characteristics and prognostic analysis of concurrent Pneumocystis jirovecii pneumonia in patients with connective tissue diseases: a retrospective study
Y. Shi, R. Chen, H. Sun, K. Xu, Z. Li, M. Wang, C. Shao, H. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/yyd4gm
Y. Shi, R. Chen, H. Sun, K. Xu, Z. Li, M. Wang, C. Shao, H. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/yyd4gm
CER18987
Uncovering CD248, MMP28, and SLC16A10 in primary Sjögren’s disease: a machine learning-driven SHAP approach for CD4+ T cell-associated biomarker discovery
Q. Wang, L. He, Y. Han
DOI: https://doi.org/10.55563/clinexprheumatol/2ffdc4
Q. Wang, L. He, Y. Han
DOI: https://doi.org/10.55563/clinexprheumatol/2ffdc4
CER18994
Exploring the comorbidity mechanism of rheumatoid arthritis and systemic lupus erythematosus through transcriptomics and conducting experimental validation
M. Shen, C. You
DOI: https://doi.org/10.55563/clinexprheumatol/1xlydo
M. Shen, C. You
DOI: https://doi.org/10.55563/clinexprheumatol/1xlydo
CER19004
Giant cell arteritis in clinical practice: beyond GiACTA
F. Regola, J. Mora, M. Riva, G. Fontana, A. Gatti, I. Cavazzana, F. Franceschini, P. Toniati
DOI: https://doi.org/10.55563/clinexprheumatol/7vcti0
F. Regola, J. Mora, M. Riva, G. Fontana, A. Gatti, I. Cavazzana, F. Franceschini, P. Toniati
DOI: https://doi.org/10.55563/clinexprheumatol/7vcti0
CER19020
Free to view
Obesity in primary Sjögren’s disease
I. Cruz-Bautista, D. Gómez-Velasco, A. García-Torralba, C.A. Aguilar-Salinas, G. Hernandez-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/9d0mr2
I. Cruz-Bautista, D. Gómez-Velasco, A. García-Torralba, C.A. Aguilar-Salinas, G. Hernandez-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/9d0mr2
CER19029
Belimumab modulates type I interferon signalling in the treatment of systemic lupus erythematosus
T. Xun, Q. Ding, Y. Ye, X. Yang, L. Mo
DOI: https://doi.org/10.55563/clinexprheumatol/03t59o
T. Xun, Q. Ding, Y. Ye, X. Yang, L. Mo
DOI: https://doi.org/10.55563/clinexprheumatol/03t59o
CER18726
Evaluating and predicting disease damage accumulation of IgG4-RD over ten years: utility of the IgG4-related Disease Damage Index
J. Li, S. Huang, Y. Wang, L. Peng, J. Zhou, Q. Luo, N. Zhang, J. Zhang, X. Yang, Y. Nie, J. Meng, M. Li, Y. Fei, W. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/tfiy6x
J. Li, S. Huang, Y. Wang, L. Peng, J. Zhou, Q. Luo, N. Zhang, J. Zhang, X. Yang, Y. Nie, J. Meng, M. Li, Y. Fei, W. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/tfiy6x
CER18913
SHP2 inhibitor mitigated renal tubular epithelial cell injury in lupus nephritis via ERK/NF-κB pathway
Y. Chen, S. Wang, S. Tan, T. Jiang, X. Li, G. Yao, L. Sun
DOI: https://doi.org/10.55563/clinexprheumatol/csqb0j
Y. Chen, S. Wang, S. Tan, T. Jiang, X. Li, G. Yao, L. Sun
DOI: https://doi.org/10.55563/clinexprheumatol/csqb0j
CER18610
Cardiac involvement in patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis
Y. Wang, X. Chen, Z. Huang, Y. Wang, W. Jiang, J. Lei, S. Xie, L. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/r1f2g9
Y. Wang, X. Chen, Z. Huang, Y. Wang, W. Jiang, J. Lei, S. Xie, L. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/r1f2g9
CER18292
Free to view
Treatment outcomes in 63 cases of juvenile dermatomyositis-associated calcinosis
B.Y. Yi, D.M. Wahezi, L. Covert, K. Ardalan, J. Hui-Yuen, N. Vasquez-Canizares, D.M. Mosa, M. Jones, C. Correll, A. Begezda, S. Shenoi, E.Y. Wu, L.K. Kovalick, W.B. Lapin, S.E. Tarvin, M.S. Oliver, M.M. Rodriguez, I. Marmor, K.W. Baszis, A.J. Taxter, A.C. Hanson, C.S. Crowson, A.B. Orandi
for the CARRA Juvenile Dermatomyositis, Calcinosis Subcommittee
DOI: https://doi.org/10.55563/clinexprheumatol/35pbbq
B.Y. Yi, D.M. Wahezi, L. Covert, K. Ardalan, J. Hui-Yuen, N. Vasquez-Canizares, D.M. Mosa, M. Jones, C. Correll, A. Begezda, S. Shenoi, E.Y. Wu, L.K. Kovalick, W.B. Lapin, S.E. Tarvin, M.S. Oliver, M.M. Rodriguez, I. Marmor, K.W. Baszis, A.J. Taxter, A.C. Hanson, C.S. Crowson, A.B. Orandi
for the CARRA Juvenile Dermatomyositis, Calcinosis Subcommittee
DOI: https://doi.org/10.55563/clinexprheumatol/35pbbq
CER18378
Free to view
Predictors of thrombotic events in patients with idiopathic inflammatory myopathies
S.S. Bae, J. Wang, A. Shahbazian, D. Markovic, Y. Lee, T. De Leon, D. Elashoff, C. Charles-Schoeman
DOI: https://doi.org/10.55563/clinexprheumatol/bj7nq2
S.S. Bae, J. Wang, A. Shahbazian, D. Markovic, Y. Lee, T. De Leon, D. Elashoff, C. Charles-Schoeman
DOI: https://doi.org/10.55563/clinexprheumatol/bj7nq2
CER18389
Free to view
The impact of first-line tumour necrosis factor inhibitor treatment on anti-infective use in patients with axial spondyloarthritis: a nationwide retrospective cohort study
H. Thorhallsdottir, A.H. Bjornsson, T.J. Love, B. Gudbjornsson
on behalf of ICEBIO
DOI: https://doi.org/10.55563/clinexprheumatol/o4irbr
H. Thorhallsdottir, A.H. Bjornsson, T.J. Love, B. Gudbjornsson
on behalf of ICEBIO
DOI: https://doi.org/10.55563/clinexprheumatol/o4irbr
CER18415
Free to view
Avacopan with combined cyclophosphamide and rituximab for induction therapy in severe ANCA-associated vasculitis: retrospective observational study of 30 patients in two German referral centres
G. Assmann, E.-B. Adjailia, S. Klapa, K. Von Allwoerden, K. Amann, R. Turkiewicz, J. Radermacher, P. Lamprecht
DOI: https://doi.org/10.55563/clinexprheumatol/7sz0zp
G. Assmann, E.-B. Adjailia, S. Klapa, K. Von Allwoerden, K. Amann, R. Turkiewicz, J. Radermacher, P. Lamprecht
DOI: https://doi.org/10.55563/clinexprheumatol/7sz0zp
CER18417
Efficacy and safety of monoclonal antibody AK111 in the treatment of active ankylosing spondylitis: a randomised, double-blind, placebo-controlled, multicentre phase II clinical study
H. Ye, S. Liu, Y. Mei, J. Gu, M. Yang, L. Zhang, G. Wang, Z. He, F. Wu, Y. Zheng, M. Xia, B. Li, Z. Li
DOI: https://doi.org/10.55563/clinexprheumatol/2t27x9
H. Ye, S. Liu, Y. Mei, J. Gu, M. Yang, L. Zhang, G. Wang, Z. He, F. Wu, Y. Zheng, M. Xia, B. Li, Z. Li
DOI: https://doi.org/10.55563/clinexprheumatol/2t27x9
CER18462
Free to view
Clinical phenotypes and therapeutic outcomes in enteropathic arthritis: a multivariate analysis from a retrospective cohort
N. Luciano, B. D'onofrio, E. Brunetta, L. Loy, C. Bezzio, G.M. Guidelli, D. Renna, A. Ceribelli, M. De Santis, A. Armuzzi, C. Selmi
DOI: https://doi.org/10.55563/clinexprheumatol/l57crv
N. Luciano, B. D'onofrio, E. Brunetta, L. Loy, C. Bezzio, G.M. Guidelli, D. Renna, A. Ceribelli, M. De Santis, A. Armuzzi, C. Selmi
DOI: https://doi.org/10.55563/clinexprheumatol/l57crv
CER18553
Free to view
Association of visceral adipose tissue with inflammation and functional impairment in women with Sjögren's disease
A.S. Franco, I.H. Murai, T.H. Yang, V.L. Bonoldi, V. De Falco Caparbo, L. Guedes, D.S. Domiciano, S.G. Pasoto, C.P. Figueiredo, R.M. Pereira
DOI: https://doi.org/10.55563/clinexprheumatol/fa4tn3
A.S. Franco, I.H. Murai, T.H. Yang, V.L. Bonoldi, V. De Falco Caparbo, L. Guedes, D.S. Domiciano, S.G. Pasoto, C.P. Figueiredo, R.M. Pereira
DOI: https://doi.org/10.55563/clinexprheumatol/fa4tn3
CER18579
Identification of biomarkers associated with pyroptosis and autophagy in facet joint osteoarthritis
X. Zhou, C. Li, T. Wang, Q. Li, G. Xu, Z. Cui
DOI: https://doi.org/10.55563/clinexprheumatol/r81nhm
X. Zhou, C. Li, T. Wang, Q. Li, G. Xu, Z. Cui
DOI: https://doi.org/10.55563/clinexprheumatol/r81nhm
CER18591
Free to view
Comprehensive magnetic resonance imaging evaluation in a cohort of 145 patients with Takayasu's arteritis. Proposal for a standardised and systematic reporting format
M.E. Soto, G. Meléndez-Ramírez, M.C. Herrera Zarza, A. Meave, M.Á. Cruz-Marmolejo, A. Mendez-Dominguez, J.S. Arias-Fernandez, M.Á. Aguirre-Delfin
DOI: https://doi.org/10.55563/clinexprheumatol/4bmcp0
M.E. Soto, G. Meléndez-Ramírez, M.C. Herrera Zarza, A. Meave, M.Á. Cruz-Marmolejo, A. Mendez-Dominguez, J.S. Arias-Fernandez, M.Á. Aguirre-Delfin
DOI: https://doi.org/10.55563/clinexprheumatol/4bmcp0
CER18771
Free to view
Pulmonary nontuberculous mycobacteria disease and anti-neutrophil cytoplasmic antibody positivity: a retrospective analysis of long-term clinical outcomes including vasculitis onset
N. Oda, H. Matsui, N. Oya, T. Suzuki, R. Hazue, R. Rokutanda
DOI: https://doi.org/10.55563/clinexprheumatol/2kjm03
N. Oda, H. Matsui, N. Oya, T. Suzuki, R. Hazue, R. Rokutanda
DOI: https://doi.org/10.55563/clinexprheumatol/2kjm03
CER18609
Free to view
Real-world outcomes of rituximab- and cyclophosphamide-based induction therapy regimens alone and in combination over 24 months in ANCA-associated vasculitis
K. Von Allwörden, S. Klapa, S.C. Werth, A. Leheis, H. Graßhoff, A. Müller, G. Riemekasten, M. Nitschke, D. Thaçi, P. Lamprecht
DOI: https://doi.org/10.55563/clinexprheumatol/cfyh9p
K. Von Allwörden, S. Klapa, S.C. Werth, A. Leheis, H. Graßhoff, A. Müller, G. Riemekasten, M. Nitschke, D. Thaçi, P. Lamprecht
DOI: https://doi.org/10.55563/clinexprheumatol/cfyh9p
CER18762
Free to view
Comparison and clinical analysis of tissue-specific autoantibodies levels in primary Sjögren's disease and other connective tissue diseases
Z.M. Wang, Y.S. Yang, X. Qi, Y. Zhang, X.P. Wang, J.L. Li, Z.Z. Huang, H.F. Guo, L.X. Gao
DOI: https://doi.org/10.55563/clinexprheumatol/tt1e0x
Z.M. Wang, Y.S. Yang, X. Qi, Y. Zhang, X.P. Wang, J.L. Li, Z.Z. Huang, H.F. Guo, L.X. Gao
DOI: https://doi.org/10.55563/clinexprheumatol/tt1e0x
CER18631
Free to view
Pneumocystis jirovecii pneumonia in anti-MDA5-positive dermatomyositis: characterisation, risk factors and prognosis
L. Yang, Q. Yang, J. Li, L. Zhang, S. Liu, C. Lian
DOI: https://doi.org/10.55563/clinexprheumatol/hpx173
L. Yang, Q. Yang, J. Li, L. Zhang, S. Liu, C. Lian
DOI: https://doi.org/10.55563/clinexprheumatol/hpx173
CER18625
Anti-SSB antibodies promotes interleukin-6 production in monocytes through a toll-like receptor4-dependent way in systemic lupus erythematosus
S.-Y. Lu, X.-M. You, F.-Q. Hu, X.-B. Mi, C.-P. Guo, G.-Z. Tan, L. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/kgit5a
S.-Y. Lu, X.-M. You, F.-Q. Hu, X.-B. Mi, C.-P. Guo, G.-Z. Tan, L. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/kgit5a
CER18652
Clinical adverse events to voclosporin: a real-world drug safety study based on FDA Adverse Event Reporting System
J. Zhang, Y. Wan, L. Liu, R. Chen, Y. Shi, Y. Tang, P. Li, H. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/qhyux8
J. Zhang, Y. Wan, L. Liu, R. Chen, Y. Shi, Y. Tang, P. Li, H. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/qhyux8
CER18654
The high prevalence of Whipple's disease in patients with inflammatory rheumatic diseases
S. Maimaris, G. Germanò, A. Torre, C. Bianco, P.I. Bianchi, C. Montecucco, A. Schiepatti, M. Frassi, G. Fontana, F. Crisafulli, L. Dardani, L. Attard, P. Cambieri, G. Arpa, C. Salvarani, A. Cavazza, A. Di Sabatino, F. Biagi
DOI: https://doi.org/10.55563/clinexprheumatol/sn44so
S. Maimaris, G. Germanò, A. Torre, C. Bianco, P.I. Bianchi, C. Montecucco, A. Schiepatti, M. Frassi, G. Fontana, F. Crisafulli, L. Dardani, L. Attard, P. Cambieri, G. Arpa, C. Salvarani, A. Cavazza, A. Di Sabatino, F. Biagi
DOI: https://doi.org/10.55563/clinexprheumatol/sn44so
CER18678
Free to view
Short Form 36 (SF-36) health survey questionnaire in health-related quality of life assessment in patients with inflammatory myopathies
A. Razok, J. Taylor, E. Ritz, K. Wipfler, K. Michaud, D. Saygin
DOI: https://doi.org/10.55563/clinexprheumatol/sbc4v3
A. Razok, J. Taylor, E. Ritz, K. Wipfler, K. Michaud, D. Saygin
DOI: https://doi.org/10.55563/clinexprheumatol/sbc4v3
CER18694
Free to view
Rheumatoid factor positivity in granulomatosis with polyangiitis: implications for clinical outcomes and immunological profiles
B. Öz, G. Yamancan, A. Karataş, S. Serdar Koca
DOI: https://doi.org/10.55563/clinexprheumatol/n373g7
B. Öz, G. Yamancan, A. Karataş, S. Serdar Koca
DOI: https://doi.org/10.55563/clinexprheumatol/n373g7
CER18720
Anifrolumab in systemic lupus erythematosus: real-world experience from a single academic tertiary care centre
P. Classen, S. Boedecker-Lips, V. Tomalla, D. Kraus, A. Kommer, M. Stortz, A. Weinmann, M. Meineck, S. Saurin, M. Plath, J. Riepl, J. Weinmann-Menke
DOI: https://doi.org/10.55563/clinexprheumatol/728zl6
P. Classen, S. Boedecker-Lips, V. Tomalla, D. Kraus, A. Kommer, M. Stortz, A. Weinmann, M. Meineck, S. Saurin, M. Plath, J. Riepl, J. Weinmann-Menke
DOI: https://doi.org/10.55563/clinexprheumatol/728zl6
CER18750
Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood: descriptive results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository
J. Pandya Bhatt, M. Dale, D.C.O. De Andrade, A.E. Clarke, M.G. Tektonidou, V. Pengo, S. Sciascia, J. Pardos-Gea, M.A. Aguirre-Zamorano, N. Kello, D. Paredes-Ruiz, H.M. Belmont, P.R. Fortin, D. Wahl, W. Branch, G. Maria, G. De Jesus, Z. Zhang, T. Atsumi, M. Efthymiou, G. Pazzola, C. Nalli, A. Duarte-García, E. Rodriguez Almaraz, M. Petri, R. Cervera, B. Artim-Esen, G. Pons-Estel, H. Shi, Y. Zuo, R. Willis, M.R. Barber, L. Skeith, M. Radin, A. Anunciacion-Llunell, M.L. Bertolaccini, H. Cohen, D. Erkan
DOI: https://doi.org/10.55563/clinexprheumatol/t46qkf
J. Pandya Bhatt, M. Dale, D.C.O. De Andrade, A.E. Clarke, M.G. Tektonidou, V. Pengo, S. Sciascia, J. Pardos-Gea, M.A. Aguirre-Zamorano, N. Kello, D. Paredes-Ruiz, H.M. Belmont, P.R. Fortin, D. Wahl, W. Branch, G. Maria, G. De Jesus, Z. Zhang, T. Atsumi, M. Efthymiou, G. Pazzola, C. Nalli, A. Duarte-García, E. Rodriguez Almaraz, M. Petri, R. Cervera, B. Artim-Esen, G. Pons-Estel, H. Shi, Y. Zuo, R. Willis, M.R. Barber, L. Skeith, M. Radin, A. Anunciacion-Llunell, M.L. Bertolaccini, H. Cohen, D. Erkan
DOI: https://doi.org/10.55563/clinexprheumatol/t46qkf
CER18756
COVID-19 in rheumatoid arthritis: prevalence, hospital admission, and risk of all-cause mortality before and after COVID-19 pandemic
M. Movahedi, X. Li, A. Cesta, C. Bombardier, E. Hepworth, S.Z. Aydin
on behalf of the OBRI investigators
DOI: https://doi.org/10.55563/clinexprheumatol/00jq99
M. Movahedi, X. Li, A. Cesta, C. Bombardier, E. Hepworth, S.Z. Aydin
on behalf of the OBRI investigators
DOI: https://doi.org/10.55563/clinexprheumatol/00jq99
CER19054
MXRA5 is identified and validated as a key gene related to epithelial-mesenchymal transition in rheumatoid arthritis fibroblast-like synoviocytes
H. Lv, Y. Li, R. Wang, Y. Gao
DOI: https://doi.org/10.55563/clinexprheumatol/dt5mf6
H. Lv, Y. Li, R. Wang, Y. Gao
DOI: https://doi.org/10.55563/clinexprheumatol/dt5mf6
CER18602
Free to view
Analysis of clinical features and risk factors for patients with idiopathic inflammatory myopathy complicated by Pneumocystis jirovecii pneumonia
J. Li, W. Huang, F. Ren, L. Luo, D. Chen, D. Huang, J. Zhou, L. Tang
DOI: https://doi.org/10.55563/clinexprheumatol/fpbkc8
J. Li, W. Huang, F. Ren, L. Luo, D. Chen, D. Huang, J. Zhou, L. Tang
DOI: https://doi.org/10.55563/clinexprheumatol/fpbkc8
CER19063
Health-related quality of life improvements and response thresholds of myositis outcome measures and response criteria
M. Almackenzie, A. Aggarwal, S. Keret, T. Chandra, R. Lomanto Silva, E. Gkiaouraki, N. Pongtarakulpanit, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
M. Almackenzie, A. Aggarwal, S. Keret, T. Chandra, R. Lomanto Silva, E. Gkiaouraki, N. Pongtarakulpanit, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
CER19069
The utility of machine learning-based decision support system in referral of suspected rheumatic disease
H. Babaoğlu, H. Satiş, Y. Kavak, A. Tufan
DOI: https://doi.org/10.55563/clinexprheumatol/31phae
H. Babaoğlu, H. Satiş, Y. Kavak, A. Tufan
DOI: https://doi.org/10.55563/clinexprheumatol/31phae
CER19080
Free to view
Modification of 2022 ACR/EULAR ANCA-associated vasculitis classification criteria in a Japanese cohort (J-CANVAS)
N. Tanaka-Mabuchi, T. Kida, S. Hanai, Y. Kobayashi, S. Omura, Y. Abe, M. Kadoya, N. Takizawa, A. Nomura, Y. Kukida, N. Kondo, Y. Yamano, T. Yanagida, K. Endo, S. Hirata, K. Matsui, T. Takeuchi, K. Ichinose, M. Kato, R. Yanai, Y. Matsuo, Y. Shimojima, R. Nishioka, R. Okazaki, T. Takata, T. Ito, M. Moriyama, A. Takatani, Y. Miyawaki, N. Yajima, T. Ito-Ihara, T. Kawaguchi, Y. Kawahito, D. Nakagomi
DOI: https://doi.org/10.55563/clinexprheumatol/5naes7
N. Tanaka-Mabuchi, T. Kida, S. Hanai, Y. Kobayashi, S. Omura, Y. Abe, M. Kadoya, N. Takizawa, A. Nomura, Y. Kukida, N. Kondo, Y. Yamano, T. Yanagida, K. Endo, S. Hirata, K. Matsui, T. Takeuchi, K. Ichinose, M. Kato, R. Yanai, Y. Matsuo, Y. Shimojima, R. Nishioka, R. Okazaki, T. Takata, T. Ito, M. Moriyama, A. Takatani, Y. Miyawaki, N. Yajima, T. Ito-Ihara, T. Kawaguchi, Y. Kawahito, D. Nakagomi
DOI: https://doi.org/10.55563/clinexprheumatol/5naes7
CER19174
Clinical significance of serum IgE/IgG4 ratio in patients with IgG4-related disease
O.C. Kwon, Y.-B. Park, K.H. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/aus9qq
O.C. Kwon, Y.-B. Park, K.H. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/aus9qq
CER19220
Patient clustering by serum inflammatory mediators stratifies early disease-modifying antirheumatic drug-naïve rheumatoid arthritis and reveals distinct pathobiological signatures: a prospective observational cohort
G. Kidoguchi, M. Ishitoku, N. Oka, H. Kobayashi, Y. Hosokawa, T. Sugimoto, Y. Yoshida, S. Mokuda, S. Hirata
DOI: https://doi.org/10.55563/clinexprheumatol/bx6ql2
G. Kidoguchi, M. Ishitoku, N. Oka, H. Kobayashi, Y. Hosokawa, T. Sugimoto, Y. Yoshida, S. Mokuda, S. Hirata
DOI: https://doi.org/10.55563/clinexprheumatol/bx6ql2
CER19292
Upadacitinib in psoriatic arthritis with prior TNF-inhibitor failure: a 56-week real-world study
U. Bakay, T. Izci Duran, O.S. Karstarli Bakay
DOI: https://doi.org/10.55563/clinexprheumatol/gniy9i
U. Bakay, T. Izci Duran, O.S. Karstarli Bakay
DOI: https://doi.org/10.55563/clinexprheumatol/gniy9i
CER19339
Drug-induced osteoporosis/osteopenia: a pharmacovigilance analysis using the FDA Adverse Event Reporting System database
Y. Wang, G. Huang, X. Fu, Z. Wang, W. Mao, G. Zheng
DOI: https://doi.org/10.55563/clinexprheumatol/9vqg6f
Y. Wang, G. Huang, X. Fu, Z. Wang, W. Mao, G. Zheng
DOI: https://doi.org/10.55563/clinexprheumatol/9vqg6f
CER19038
Treatment sequences and lines of therapy in rheumatoid arthritis: a real-world evaluation of retention and effectiveness
M. Movahedi, B. Kuriya, A. Cesta, X. Li, S.Z. Aydin, C. Bombardier, P. Akhavan
on behalf of Ontario Best Practices Initiative (OBRI) Investigators, UHN, Toronto, Canada.
DOI: https://doi.org/10.55563/clinexprheumatol/y1vbr1
M. Movahedi, B. Kuriya, A. Cesta, X. Li, S.Z. Aydin, C. Bombardier, P. Akhavan
on behalf of Ontario Best Practices Initiative (OBRI) Investigators, UHN, Toronto, Canada.
DOI: https://doi.org/10.55563/clinexprheumatol/y1vbr1
Review
CER18827
Applications of ultrasound in autoimmune diseases: a bibliometric study (2008-2024)
Z. Qiu, W. Zhu, J. Zhou, Y. Shen, R. Xia, K. Yang, Z. Li, Y. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/53qm54
Z. Qiu, W. Zhu, J. Zhou, Y. Shen, R. Xia, K. Yang, Z. Li, Y. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/53qm54
CER19305
Free to view
Clinical manifestations, imaging and treatment of Sjögren's disease: one year in review 2025
L.G. Chatzis, V. Manfrè, A. Colangelo, K. Delli, S. Arends, A.G. Tzioufas, H. Bootsma, L. Quartuccio, E. Bartoloni
DOI: https://doi.org/10.55563/clinexprheumatol/pjs5h9
L.G. Chatzis, V. Manfrè, A. Colangelo, K. Delli, S. Arends, A.G. Tzioufas, H. Bootsma, L. Quartuccio, E. Bartoloni
DOI: https://doi.org/10.55563/clinexprheumatol/pjs5h9
CER19096
Free to view
Efficacy and safety of tocilizumab in polyarteritis nodosa and adenosine deaminase 2 deficiency: a systematic literature review
E.S. Torun, S. Çelen
DOI: https://doi.org/10.55563/clinexprheumatol/477rzo
E.S. Torun, S. Çelen
DOI: https://doi.org/10.55563/clinexprheumatol/477rzo
CER19016
The potential role of neutrophils in connective tissue disease-associated interstitial lung disease
H. Wang, Y. Lu, J. Liu, Z. Sang, W. Fan, Y. Liu, J. Lin
DOI: https://doi.org/10.55563/clinexprheumatol/su8rvb
H. Wang, Y. Lu, J. Liu, Z. Sang, W. Fan, Y. Liu, J. Lin
DOI: https://doi.org/10.55563/clinexprheumatol/su8rvb
CER18875
Is there place for TNF-alpha inhibitors in the treatment of connective tissue diseases?
A. Matusiewicz, M. Dziewit, S. Ornowska, M. Olesińska
DOI: https://doi.org/10.55563/clinexprheumatol/r24pfo
A. Matusiewicz, M. Dziewit, S. Ornowska, M. Olesińska
DOI: https://doi.org/10.55563/clinexprheumatol/r24pfo
CER18815
Rheumatoid arthritis: emerging insights into molecular mechanisms and targeted immunotherapy
W. Yang, J. Chen, X. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/dgbqaa
W. Yang, J. Chen, X. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/dgbqaa
CER18776
Research progress of NLRP3 in immune cells of systemic lupus erythematosus
Y. Liu, Y. Wang, X. Wang, Y. Liu, Y. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/xmghi4
Y. Liu, Y. Wang, X. Wang, Y. Liu, Y. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/xmghi4
CER18721
Research trends and hotspots on gut microbiota in rheumatoid arthritis: a bibliometric analysis from 2004 to 2024
Z. Zheng, X. Liu, Y. Zhang, H. Zhang, S. Chen, J. Zhu
DOI: https://doi.org/10.55563/clinexprheumatol/3899sf
Z. Zheng, X. Liu, Y. Zhang, H. Zhang, S. Chen, J. Zhu
DOI: https://doi.org/10.55563/clinexprheumatol/3899sf
CER18606
The microbiota in axial spondyloarthritis: what have we learned from Mendelian randomisation studies?
M.L. Stoll, M. Appah, H.K. Tiwari
DOI: https://doi.org/10.55563/clinexprheumatol/rvb37m
M.L. Stoll, M. Appah, H.K. Tiwari
DOI: https://doi.org/10.55563/clinexprheumatol/rvb37m
CER18953
Red wine antioxidant properties implications in rheumatic diseases: exploring clonal variations in resveratrol and other bioactive compounds
F. Belli, F. Bandinelli, R. Bandinelli, M. Pagano
DOI: https://doi.org/10.55563/clinexprheumatol/pybjjj
F. Belli, F. Bandinelli, R. Bandinelli, M. Pagano
DOI: https://doi.org/10.55563/clinexprheumatol/pybjjj
LER & CER: letter to Editor Rheumatology
CER18494
Free to view
Sacroiliitis and familial Mediterranean fever: unresolved questions
M.E. Güveli, H. Güveli
DOI: https://doi.org/10.55563/clinexprheumatol/8zi6z2
M.E. Güveli, H. Güveli
DOI: https://doi.org/10.55563/clinexprheumatol/8zi6z2
CER18688
Free to view
Isolated positivity for anti-ribosomal P antibodies and its utility in clinical practice: a literature review and description of 16 cases
T. Blázquez-Sánchez, M.B. Just-Balerdi, K. Guzmán-López, A. Torres-Roselló, E. Heras-Recuero, A. García-Fernández, F. Rengifo-García, C. Caraballo-Salazar, M.J. Martínez-Becerra, M.C. Vegas-Sánchez, M.Á. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/b5v910
T. Blázquez-Sánchez, M.B. Just-Balerdi, K. Guzmán-López, A. Torres-Roselló, E. Heras-Recuero, A. García-Fernández, F. Rengifo-García, C. Caraballo-Salazar, M.J. Martínez-Becerra, M.C. Vegas-Sánchez, M.Á. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/b5v910
CER19239
Free to view
Reply to: Use of upadacitinib in giant cell arteritis
D. Blockmans, W. Zhao, A.R. Setty, P.A. Merkel
DOI: https://doi.org/10.55563/clinexprheumatol/ozaczo
D. Blockmans, W. Zhao, A.R. Setty, P.A. Merkel
DOI: https://doi.org/10.55563/clinexprheumatol/ozaczo
CER19049
Free to view
Use of upadacitinib in giant cell arteritis
H. Ogun, Y. Ozguler
DOI: https://doi.org/10.55563/clinexprheumatol/5ozvlt
H. Ogun, Y. Ozguler
DOI: https://doi.org/10.55563/clinexprheumatol/5ozvlt
CER18988
Free to view
The risk stage of subclinical inflammation is not comparable to the stage of clinical arthritis. Response to ‘comments and perspectives on the TREAT EARLIER study’
Q.A. Dumoulin, A.H. Van der helm-Van mil
DOI: https://doi.org/10.55563/clinexprheumatol/7454k1
Q.A. Dumoulin, A.H. Van der helm-Van mil
DOI: https://doi.org/10.55563/clinexprheumatol/7454k1
CER18934
Free to view
Comment on: Evaluation of the nocebo effect after switching from etanercept or adalimumab originator to a biosimilar: a retrospective study of patients with inflammatory rheumatism
V. Torrente-Segarra, C. Rojas, M. Bonet
DOI: https://doi.org/10.55563/clinexprheumatol/v0g0cd
V. Torrente-Segarra, C. Rojas, M. Bonet
DOI: https://doi.org/10.55563/clinexprheumatol/v0g0cd
CER18806
Free to view
Exploring the ‘risk’: Comments on the FAERS data regarding the safety of JAK inhibitors by Mikaeili et al.
E. Bilgin
DOI: https://doi.org/10.55563/clinexprheumatol/9m9nbq
E. Bilgin
DOI: https://doi.org/10.55563/clinexprheumatol/9m9nbq
CER18775
Free to view
Beyond the ratios: what influences neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in paediatric systemic lupus erythematosus?
F. Demircioğlu
DOI: https://doi.org/10.55563/clinexprheumatol/k79lo4
F. Demircioğlu
DOI: https://doi.org/10.55563/clinexprheumatol/k79lo4
CER18512
Free to view
First report on the safety of the influenza vaccine in patients with paediatric inflammatory rheumatic diseases on JAK inhibitors
D.N. Maritsi, L. Mentesidou, A. Syggelou, M.N. Tsolia
DOI: https://doi.org/10.55563/clinexprheumatol/hlidn3
D.N. Maritsi, L. Mentesidou, A. Syggelou, M.N. Tsolia
DOI: https://doi.org/10.55563/clinexprheumatol/hlidn3
CER18450
Free to view
Comments and perspectives on the TREAT EARLIER study
E. Bilgin
DOI: https://doi.org/10.55563/clinexprheumatol/gian28
E. Bilgin
DOI: https://doi.org/10.55563/clinexprheumatol/gian28
CER18358
Free to view
Uncertainties in colchicine response criteria in elderly familial Mediterranean fever
M.E. Güveli, H. Güveli
DOI: https://doi.org/10.55563/clinexprheumatol/am59md
M.E. Güveli, H. Güveli
DOI: https://doi.org/10.55563/clinexprheumatol/am59md
CER18362
Free to view
Safety of mycophenolate mofetil in Behçet's disease: a single centre retrospective study
D. Kerim, F. Tastekin, S. Koroglu, G. Keser, Y. Kabasakal, K. Aksu
DOI: https://doi.org/10.55563/clinexprheumatol/samn0p
D. Kerim, F. Tastekin, S. Koroglu, G. Keser, Y. Kabasakal, K. Aksu
DOI: https://doi.org/10.55563/clinexprheumatol/samn0p
CER18225
Free to view
Questioning the diagnosis of familial Mediterranean fever based solely on MEFV mutation: a critical review of overlapping features with inflammatory bowel disease
M.E. Güveli, H. Güveli
DOI: https://doi.org/10.55563/clinexprheumatol/0x0ssk
M.E. Güveli, H. Güveli
DOI: https://doi.org/10.55563/clinexprheumatol/0x0ssk
CER18668
Free to view
Should multisystem inflammatory syndrome in children be considered occult macrophage activation syndrome?
J.W. Rhim, S.-Y. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/hc0ukd
J.W. Rhim, S.-Y. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/hc0ukd
CER18522
Free to view
Use of mycophenolate mofetil in new-onset systemic lupus erythematosus
H. Ogun, S.N. Esatoglu
DOI: https://doi.org/10.55563/clinexprheumatol/fece6x
H. Ogun, S.N. Esatoglu
DOI: https://doi.org/10.55563/clinexprheumatol/fece6x
Rapid paper
CER18299
Free to view
GITR/GITRL interaction promotes the expansion of T helper 9 and T helper 17 in psoriatic arthritis
L. La Barbera, C. Rizzo, M. Lo Pizzo, D. Di Liberto, M.P. La Manna, L. Mohammadnezhad, F. Camarda, G. Sireci, F. Ciccia, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/31hjvf
L. La Barbera, C. Rizzo, M. Lo Pizzo, D. Di Liberto, M.P. La Manna, L. Mohammadnezhad, F. Camarda, G. Sireci, F. Ciccia, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/31hjvf
Letters to the Editor
CER18472
Free to view
Comment on: Beyond diagnosis: exploring the significance of IgG4+ plasma cell count through immunostaining in IgG4-related disease
M.-W. Chiang, P.-C. Wu
DOI: https://doi.org/10.55563/clinexprheumatol/fr0v5l
M.-W. Chiang, P.-C. Wu
DOI: https://doi.org/10.55563/clinexprheumatol/fr0v5l
CER19130
Free to view
Comments on: Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis
G. Chen, L.M. Zhang, Y. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/5ynhsh
G. Chen, L.M. Zhang, Y. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/5ynhsh
CER18967
Free to view
Comment on: Triple-combination therapy did not improve prognosis in anti-MDA5 positive dermatomyositis: a multicentre longitudinal cohort study by You et al.
W. Rojas-Zuleta
DOI: https://doi.org/10.55563/clinexprheumatol/spyyh8
W. Rojas-Zuleta
DOI: https://doi.org/10.55563/clinexprheumatol/spyyh8
CER18960
Free to view
Synovial biopsy in a case of nivolumab-induced arthritis
R. Pereira Da Costa, M. Pinho, J. Patrocínio, S. Torres, C. Ferreira, J.E. Fonseca, N. Khmelinskii
DOI: https://doi.org/10.55563/clinexprheumatol/2z7vho
R. Pereira Da Costa, M. Pinho, J. Patrocínio, S. Torres, C. Ferreira, J.E. Fonseca, N. Khmelinskii
DOI: https://doi.org/10.55563/clinexprheumatol/2z7vho
CER18908
Free to view
Dermatomyositis assessment of rash via telemedicine: a prospective study
N. Pongtarakulpanit, A. Bishnoi, D.P. Ascherman, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/g16i0y
N. Pongtarakulpanit, A. Bishnoi, D.P. Ascherman, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/g16i0y
CER18791
Free to view
Successful therapy of refractory dermatomyositis skin rash with anifrolumab
C. Galluzzo, N. Pipitone, I. Chiapparoli, C. Salvarani
DOI: https://doi.org/10.55563/clinexprheumatol/haftre
C. Galluzzo, N. Pipitone, I. Chiapparoli, C. Salvarani
DOI: https://doi.org/10.55563/clinexprheumatol/haftre
CER18769
Free to view
Undifferentiated spondyloarthritis with late onset large vessel vasculitis and upadacitinib induced remission
N. Ahmed, K.J. Warrington, M.J. Koster
DOI: https://doi.org/10.55563/clinexprheumatol/8ocj7h
N. Ahmed, K.J. Warrington, M.J. Koster
DOI: https://doi.org/10.55563/clinexprheumatol/8ocj7h
CER18766
Free to view
Discovering four sacroiliac joints in a patient with spondylarthritis
G.A. Drosos, A.K. Zikou, P.V. Voulgari, A.A. Drosos
DOI: https://doi.org/10.55563/clinexprheumatol/o4jl8q
G.A. Drosos, A.K. Zikou, P.V. Voulgari, A.A. Drosos
DOI: https://doi.org/10.55563/clinexprheumatol/o4jl8q
CER18578
Free to view
Reply to the comment on: Beyond diagnosis: exploring the significance of IgG4+ plasma cell count through immunostaining in IgG4-related disease
E. Martín-Nares, G. Hernández-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/0mrihy
E. Martín-Nares, G. Hernández-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/0mrihy
CER18520
Free to view
Recurrent myocarditis revealing a desmoplakin cardiomyopathy successfully treated with anakinra
T. Barba, M. Robert, A. Hot
DOI: https://doi.org/10.55563/clinexprheumatol/vxe3tj
T. Barba, M. Robert, A. Hot
DOI: https://doi.org/10.55563/clinexprheumatol/vxe3tj
CER19415
Free to view
Successful treatment of a rare case of coronary vasculitis associated to diffuse large B-cell lymphoma in Sjögren’s disease
V. Manfrè, A. Nano, M.T. Rizzo, S. Longhino, L. Quartuccio
V. Manfrè, A. Nano, M.T. Rizzo, S. Longhino, L. Quartuccio
CER19189
Free to view
Reply to the comments on: Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis
S. Klapa, L. Schumacher, P. Lamprecht
on behalf of all authors.
DOI: https://doi.org/10.55563/clinexprheumatol/eaaqk8
S. Klapa, L. Schumacher, P. Lamprecht
on behalf of all authors.
DOI: https://doi.org/10.55563/clinexprheumatol/eaaqk8
CER18537
Free to view
Telitacicept in combination with conventional therapy for rapid steroid reduction in lupus mesenteric vasculitis and lupus nephritis: a case report
M. Wang, Y. Xu, S. Wang, C. Li
DOI: https://doi.org/10.55563/clinexprheumatol/2mc79a
M. Wang, Y. Xu, S. Wang, C. Li
DOI: https://doi.org/10.55563/clinexprheumatol/2mc79a